000			02902nam a2200517 i 4500
999			_c286904 _d286904
001			on1085907023
003			OCoLC
005			20190920130521.0
007			he bmb024bbca
008			190215s2017 dcua bb f000 0 eng c
040			_aPUCPR _beng _erda _cNTE _dUND _dGPO _dMvI
042			_apcc
043			_an-us---
074			_a1043-B (MF)
086	0		_aY 4.L 11/4:S.HRG.114-700
099			_aY 4.L 11/4:S.HRG.114-700
110	1		_aUnited States. _bCongress. _bSenate. _bCommittee on Health, Education, Labor, and Pensions. _bSubcommittee on Primary Health and Retirement Security,
245	1	0	_aBiosimilar implementation : _ba progress report from FDA : hearing before the Subcommittee on Primary Health and Retirement Security of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, first session, on examining biosimilar implementation, focusing on a progress report from FDA, September 17, 2015.
246	3		_aBiosimilar implementation : _ba progress report from Food and Drug Administration
264		1	_aWashington : _bU.S. Government Publishing Office, _c2017.
264		2	_aWashington, DC : _bFor sale by the Superintendent of Documents, U.S. Government Publishing Office
300			_aiii, 40 pages : _billustrations ; _c24 cm.
336			_btxt
337			_bh _2rdamedia
338			_bhe _2rdacarrier
490	1		_aS. hrg. ; _v114-700
500			_aShipping list no.: 2018-0124-M.
500			_aCRDP Program record.
504			_aIncludes bibliographical references.
533			_aMicrofiche. _b[Washington, D.C.] : _cU.S. Government Printing Office, _d[2017] _e1 microfiche : negative.
776	0	8	_iPrint version: _aUnited States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Retirement Security. _tBiosimilar implementation _w(DLC) 2017434987 _w(OCoLC)1009576707
776	0	8	_iOnline version: _aUnited States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Retirement Security. _tBiosimilar implementation _w(OCoLC)1010499051
810	1		_aUnited States. _bCongress. _bSenate. _tS. hrg. ; _v114-700.
050		4	_aKF26 _b.L2774 2015a
610	1	0	_aUnited States. _bFood and Drug Administration _xRules and practice.
610	1	7	_aUnited States. _bFood and Drug Administration. _2fast
650		0	_aPharmaceutical biotechnology _zUnited States _xManagement.
650		0	_aPharmaceutical biotechnology _xGovernment policy _zUnited States.
650		0	_aDrug development _xGovernment policy _zUnited States.
650		0	_aDrugs _xGeneric substitution _xGovernment policy _zUnited States.
651		7	_aUnited States. _2fast
655		7	_aLegislative hearings. _2lcgft
655		7	_aLegislative hearings. _2fast
655		7	_aRules. _2fast
942			_2sudocs _c8